Viewing Study NCT00589420


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2025-12-26 @ 3:04 AM
Study NCT ID: NCT00589420
Status: COMPLETED
Last Update Posted: 2022-02-17
First Post: 2007-12-25
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Sorafenib and Docetaxel in Patients With Prostate Cancer That Did Not Respond to Previous Hormone Therapy
Sponsor: Abramson Cancer Center at Penn Medicine
Organization: